[YTL] YoY Annualized Quarter Result on 30-Sep-2015 [#1]

Stock
[YTL] YTL CORPORATION BHD
Announcement Date
26-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2016
Quarter
30-Sep-2015 [#1]
Profit Trend
QoQ- -20.36%
YoY- -6.25%
Quarter Report
Latest QR
Upcoming QR
YTL's Result
YTL's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 16,354,092 15,719,448 13,968,600 17,793,556 17,937,120 20,842,992 20,288,520 -3.52%
PBT 1,367,780 1,760,352 1,385,180 2,866,408 2,020,708 2,628,772 2,601,612 -10.15%
Tax -310,040 -522,128 -332,584 -1,589,164 -519,796 -249,200 -465,088 -6.53%
NP 1,057,740 1,238,224 1,052,596 1,277,244 1,500,912 2,379,572 2,136,524 -11.05%
-
NP to SH 503,160 571,588 601,320 810,460 864,512 1,710,248 1,567,720 -17.24%
-
Tax Rate 22.67% 29.66% 24.01% 55.44% 25.72% 9.48% 17.88% -
Total Cost 15,296,352 14,481,224 12,916,004 16,516,312 16,436,208 18,463,420 18,151,996 -2.81%
-
Net Worth 14,274,538 15,065,349 15,032,999 15,770,548 14,374,063 14,113,697 11,864,878 3.12%
Dividend
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Div - - - - - 622,663 3,890 -
Div Payout % - - - - - 36.41% 0.25% -
Equity
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Net Worth 14,274,538 15,065,349 15,032,999 15,770,548 14,374,063 14,113,697 11,864,878 3.12%
NOSH 10,910,559 10,910,559 10,439,582 10,444,071 10,341,053 10,377,718 9,725,309 1.93%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin 6.47% 7.88% 7.54% 7.18% 8.37% 11.42% 10.53% -
ROE 3.52% 3.79% 4.00% 5.14% 6.01% 12.12% 13.21% -
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 154.67 149.21 133.80 170.37 173.46 200.84 208.62 -4.86%
EPS 4.76 5.44 5.76 7.76 8.36 16.48 16.12 -18.38%
DPS 0.00 0.00 0.00 0.00 0.00 6.00 0.04 -
NAPS 1.35 1.43 1.44 1.51 1.39 1.36 1.22 1.70%
Adjusted Per Share Value based on latest NOSH - 10,444,071
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 147.35 141.63 125.85 160.31 161.61 187.79 182.79 -3.52%
EPS 4.53 5.15 5.42 7.30 7.79 15.41 14.12 -17.25%
DPS 0.00 0.00 0.00 0.00 0.00 5.61 0.04 -
NAPS 1.2861 1.3573 1.3544 1.4209 1.2951 1.2716 1.069 3.12%
Price Multiplier on Financial Quarter End Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 -
Price 1.25 1.36 1.79 1.60 1.68 1.54 1.72 -
P/RPS 0.81 0.91 1.34 0.94 0.97 0.77 0.82 -0.20%
P/EPS 26.27 25.07 31.08 20.62 20.10 9.34 10.67 16.19%
EY 3.81 3.99 3.22 4.85 4.98 10.70 9.37 -13.92%
DY 0.00 0.00 0.00 0.00 0.00 3.90 0.02 -
P/NAPS 0.93 0.95 1.24 1.06 1.21 1.13 1.41 -6.69%
Price Multiplier on Announcement Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 23/11/18 22/11/17 17/11/16 26/11/15 20/11/14 21/11/13 22/11/12 -
Price 1.15 1.20 1.55 1.54 1.64 1.62 1.74 -
P/RPS 0.74 0.80 1.16 0.90 0.95 0.81 0.83 -1.89%
P/EPS 24.17 22.12 26.91 19.85 19.62 9.83 10.79 14.37%
EY 4.14 4.52 3.72 5.04 5.10 10.17 9.26 -12.55%
DY 0.00 0.00 0.00 0.00 0.00 3.70 0.02 -
P/NAPS 0.85 0.84 1.08 1.02 1.18 1.19 1.43 -8.30%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment